RESUMEN

In the pre-direct-acting antiviral era, hepatitis C virus (HCV) treatments were complex and largely managed by hepatologists, gastroenterologists, and infectious disease physicians. As direct-acting antivirals have driven up demand for treatment, the relative scarcity of these specialists has created a bottleneck effect, resulting in only a fraction of HCV-infected individuals offered treatment. The San Francisco Health Network is a safety net system of care. Its intervention was designed to be sustainable and scalable; with minimal time commitments for training providers, primary care-based HCV treatment increased 3-fold in a period of just over 3 years.

Asunto(s)

Antivirales/uso terapéutico , Hepatitis C Crónica/tratamiento farmacológico , Hepatitis C/tratamiento farmacológico , Atención Primaria de Salud , Antivirales/administración & dosificación , Antivirales/efectos adversos , Hepacivirus/efectos de los fármacos , Hepatitis C/epidemiología , Hepatitis C/virología , Hepatitis C Crónica/epidemiología , Hepatitis C Crónica/virología , Humanos , Médicos , San Francisco/epidemiología

Asunto(s)

Atención Primaria de Salud , Humanos